Since 2010, the World Clinical Biomarkers & Companion Diagnostics Series has been at the centre of the biomarker and diagnostic community, gathering thought leaders and pioneers in the biomarker, CDx and precision medicine fields across Europe and North America.  

Providing a much-needed platform for candid conversations on how to define, adopt and implement a CDx strategy to ensure your drug candidates are regulatory compliant, achieve reimbursement and gain market share, the event series is dedicated to helping to bring the right drug, to the right patient, at the right time.  

As precision medicine within the Asia-Pacific region surges, we are excited to bring our conference series to Singapore for the first time, creating an industry hub to discover and translate novel predictive biomarker signatures into clinically validated companion diagnostic assays for precision medicine candidates.